Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes

Surgical Oncology - Tập 36 - Trang 138-146 - 2021
Phillip M. Kemp Bohan1, Anne E. O'Shea1, Andrew J. Lee2, Robert C. Chick1, Timothy E. Newhook3, Hop S. Tran Cao3, Casey J. Allen3, Daniel W. Nelson4, G. Travis Clifton1, Jean-Nicolas Vauthey3, Ching-Wei D. Tzeng3, Timothy J. Vreeland1,3
1Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, TX, USA
2Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
3Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
4Department of Surgical Oncology, William Beaumont Army Medical Center, El Paso, TX, USA

Tài liệu tham khảo

Yang, 2019, Prevalence and clinical significance of regional lymphadenectomy in patients with hepatocellular carcinoma, ANZ J. Surg., 89, 393, 10.1111/ans.15096

Ercolani, 2004, The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy, Ann. Surg., 239, 202, 10.1097/01.sla.0000109154.00020.e0

Xiaohong, 2010, Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma, World J. Surg., 34, 1028, 10.1007/s00268-010-0400-0

Sun, 2007, Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy, J. Surg. Oncol., 96, 37, 10.1002/jso.20772

Watanabe, 1994, Clinicopathologic study on lymph node metastasis of hepatocellular carcinoma: a retrospective study of 660 consecutive autopsy cases, Jpn. J. Clin. Oncol., 24, 37

Kaczynski, 1995, Metastases in cases with hepatocellular carcinoma in relation to clinicopathologic features of the tumor. An autopsy study from a low endemic area, Acta Oncol., 34, 43, 10.3109/02841869509093637

Wu, 2015, Hepatectomy versus hepatectomy with lymphadenectomy in hepatocellular carcinoma: a prospective, randomized controlled clinical trial, J. Clin. Gastroenterol., 49, 520, 10.1097/MCG.0000000000000277

Bilimoria, 2008, The National Cancer Data Base: a powerful initiative to improve cancer care in the United States, Ann. Surg Oncol., 15, 683, 10.1245/s10434-007-9747-3

Amini, 2014, Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review, J. Gastrointest. Surg., 18, 2136, 10.1007/s11605-014-2667-1

Grobmyer, 2006, Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy, Ann. Surg., 244, 260, 10.1097/01.sla.0000217606.59625.9d

Uka, 2007, Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma, World J. Gastroenterol., 13, 414, 10.3748/wjg.v13.i3.414

Lee, 2011, Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome, Asian J. Surg., 34, 53, 10.1016/S1015-9584(11)60020-1

Sangro, 2016, A randomized, multicenter, phase 3 study of nivolumab vs sorafenib as first-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): CheckMate-459, J. Clin. Oncol., 34, 10.1200/JCO.2016.34.15_suppl.4078

Abou-Alfa, 2018, A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study, J. Clin. Oncol., 36, 10.1200/JCO.2018.36.15_suppl.TPS4144

Ishii, 2000, Perihepatic lymphadenopathy in chronic liver diseases, J. Gastroenterol. Hepatol., 15, 695, 10.1046/j.1440-1746.2000.02208.x

del Olmo, 2002, Clinical significance of abdominal lymphadenopathy in chronic liver disease, Ultrasound Med. Biol., 28, 297, 10.1016/S0301-5629(01)00514-2

Dodd, 1997, Enlarged abdominal lymph nodes in end-stage cirrhosis: CT-histopathologic correlation in 507 patients, Radiology, 203, 127, 10.1148/radiology.203.1.9122379

Bruix, 2015, Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial, Lancet Oncol., 16, 1344, 10.1016/S1470-2045(15)00198-9

2019, National comprehensive cancer network clinical practice guidelines in Oncology: Hepatobiliary, Cancers

Thông tin
Thông tin xuất bản

Surgical Oncology

Tập 36

138-146

Thông tin tác giả